Company news
Champions Oncology, Inc. (NASDAQ:CSBR) news
Every Champions Oncology, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Champions Oncology Reports Record Annual Revenue of $59 Million
July 27, 2026
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
July 20, 2026
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
March 30, 2026
Champions Oncology Reports Revenue of $16.6 Million
March 12, 2026
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
March 5, 2026
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
December 15, 2025
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
December 8, 2025
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
September 15, 2025
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
September 15, 2025
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
September 10, 2025
Champions Oncology Reports Record Annual Revenue of $57 Million
July 23, 2025
Champions Oncology Reports Record Annual Revenue of $57 Million
July 23, 2025
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
July 21, 2025
Champions Oncology Announces Appointment of New CEO
July 18, 2025
Champions Oncology Announces Appointment of New CEO
July 18, 2025
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
July 8, 2025
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
April 28, 2025
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
April 24, 2025
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
March 11, 2025
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
March 6, 2025
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
February 18, 2025
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
January 8, 2025
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
December 11, 2024
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
December 5, 2024
Champions Oncology Announces Agreement with Weill Cornell Medicine
October 16, 2024
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
September 11, 2024
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
September 9, 2024
Champions Oncology Reports Quarterly Revenue of $14.0 Million
July 18, 2024
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
July 11, 2024
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
June 4, 2024
Champions Oncology Reports Quarterly Revenue of $12.0 Million
March 12, 2024
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
March 7, 2024
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
March 6, 2024
Champions Oncology Reports Quarterly Revenue of $11.6 Million
December 12, 2023
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
December 4, 2023
El centro europeo de operaciones de investigación de Champions Oncology recibe la acreditación ISO-9001:2015 y la certificación ATS
November 2, 2023
Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung
November 2, 2023
Champions Oncology Announces the Addition of Brady Davis as President
October 17, 2023
Champions Oncology Reports Quarterly Revenue of $12.6 Million
September 13, 2023
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
September 11, 2023
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
August 22, 2023
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinica...
August 1, 2023
Champions Oncology Reports Quarterly Revenue of $13.1 Million
July 24, 2023
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
July 20, 2023
Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Th...
April 17, 2023
Champions Oncology Announces $5M Stock Repurchase Program
April 5, 2023
CHAMPIONS ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
March 16, 2023
Champions Oncology Reports Quarterly Revenue of $12.8 Million
March 15, 2023
Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023
March 13, 2023
Champions Oncology : Reports Record Quarterly Revenue of $14.3 Million
December 14, 2022